What are the various types of anesthetic agents and the clinical situations in which each should be used?

Types of Anesthesia and Their Clinical Applications

Regional anesthesia should be prioritized whenever possible, as it reduces contamination risk, preserves drug supplies, and provides superior postoperative analgesia with fewer complications compared to general anesthesia 1.

Main Categories of Anesthesia

1. Local Anesthesia

Local anesthetics block sodium channels in peripheral nerves to prevent pain signal transmission 2.

Common agents and maximum doses:

Amide local anesthetics (preferred - lower allergy risk):

• Lidocaine: 7 mg/kg with epinephrine, 4.4 mg/kg without; duration 90-200 minutes 3
• Bupivacaine: 3 mg/kg with epinephrine, 2.5 mg/kg without; duration 180-600 minutes 3
• Ropivacaine: 3 mg/kg; duration 180-600 minutes 3
• Levobupivacaine: 3 mg/kg; duration 180-600 minutes 3

Critical dosing considerations:

• Reduce amide doses by 30% in infants <6 months 4
• Calculate maximum safe dose before administration to prevent toxicity 3
• Use lower doses in highly vascular areas 3

When to use:

• Minor procedures (suturing, biopsies, dental work)
• Wound infiltration
• Nerve blocks for specific anatomical regions
• As adjunct to general or regional anesthesia

---

2. Regional Anesthesia

Neuraxial blocks (epidural/spinal):

Epidural anesthesia:

• Thoracic epidural: 0.2-0.3 ml/kg bupivacaine 0.25% or ropivacaine 0.2% (max 10ml initially) 5
• Lumbar epidural: 0.5 ml/kg bupivacaine 0.25% or ropivacaine 0.2% (max 15ml initially) 5
• Caudal block: 1.0 ml/kg bupivacaine 0.25% or ropivacaine 0.2% 5

When to use:

• Major abdominal surgery (reduces pulmonary complications and chronic pain) 6
• Thoracic procedures
• Lower extremity surgery
• Labor analgesia
• Postoperative pain management

Peripheral nerve blocks:

• Femoral/fascia iliaca block: 0.2-0.5 ml/kg bupivacaine 0.25% 5
• Paravertebral block: 0.2-0.5 ml/kg bupivacaine 0.25% 5

When to use:

• Orthopedic procedures (fracture reductions, joint surgery)
• Limb surgery
• Procedures where general anesthesia poses higher risk

---

3. General Anesthesia

General anesthesia produces unconsciousness, amnesia, analgesia, and muscle relaxation 7.

Intravenous Induction Agents

Propofol (preferred for induction):

• Rapid onset, smooth induction, rapid clearance 7
• Avoid claustrophobia of mask induction 7
• Use with caution in egg/soy allergy (though manufacturing likely removes allergenic proteins) 8

Ketamine:

• Level A recommendation for pediatric procedural sedation 9
• Dissociative anesthetic with preserved airway reflexes
• Useful for painful procedures in children
• 2 mg/kg IV after 0.07 mg/kg midazolam 9

Etomidate:

• Level C recommendation for procedural sedation 9
• Minimal cardiovascular depression
• Side effects: myoclonus (0-21%), injection pain 9
• 5% desaturation rate, all recovered uneventfully 9

Midazolam:

• Benzodiazepine sedative
• Often combined with opioids (fentanyl) for procedural sedation 9
• Level B recommendation when combined with fentanyl 9

When to use IV agents:

• Rapid sequence intubation
• Procedures requiring complete unconsciousness
• When airway control is needed
• Hemodynamically unstable patients (etomidate preferred)

Inhaled Anesthetic Agents

Preferred for maintenance of anesthesia - allow precise control at low cost 7.

Modern volatile agents:

• Sevoflurane: Smooth induction, minimal airway irritation, moderate solubility 10
• Desflurane: Low solubility (rapid emergence), respiratory irritant 10
• Isoflurane: Adequate potency, appropriate solubility, minimal hepatotoxicity 10

Avoid:

• Halothane: Too soluble, risk of severe hepatotoxicity 7
• Nitrous oxide: Insufficient potency alone 7

Cardioprotective properties:

• Volatile agents recommended for major non-cardiac surgery in patients with heart disease 6
• Demonstrated cardioprotection during cardiac surgery 6

When to use:

• Maintenance of general anesthesia after IV induction
• Prolonged procedures
• Patients with cardiac disease (volatile agents preferred)
• When precise depth control needed

---

4. Procedural Sedation

Moderate sedation (conscious sedation):

• Patient responds purposefully to verbal/light tactile stimulation
• Maintains protective airway reflexes 11

Deep sedation:

• Not easily aroused, responds to repeated/painful stimulation
• May need airway assistance 11

Key agents:

• Propofol: Level B recommendation, safe for procedural sedation 9
• Fentanyl + Midazolam: Level B recommendation, effective combination 9
• Dexmedetomidine: Alternative to benzodiazepines, lower hypoxemia risk when combined with opioids 12

Critical monitoring requirements:

• Continuous oxygen saturation, heart rate, ventilation 3
• Capnography required for deep sedation 3
• Document vitals every 5 minutes (deep sedation) or 10 minutes (moderate sedation) 3
• Maintain IV access throughout procedure 12

---

Clinical Decision Algorithm

Step 1: Assess procedure invasiveness and duration

• Minor, brief, superficial → Local anesthesia
• Moderate pain, specific anatomical region → Regional anesthesia
• Major surgery, need for unconsciousness → General anesthesia

Step 2: Evaluate patient factors

• ASA III-IV, cardiac disease → Regional preferred or volatile agents if general needed 6
• Pediatric fracture reduction → Ketamine (Level A) 9
• Emergency with unknown COVID status → Rapid sequence with video laryngoscope 1

Step 3: Consider postoperative needs

• Major surgery requiring prolonged analgesia → Epidural anesthesia (reduces complications) 6
• Outpatient procedure → Agents with rapid recovery (propofol, sevoflurane)

Step 4: Resource considerations

• Drug shortages → Prioritize regional techniques 1
• Limited monitoring → Avoid deep sedation

---

Critical Safety Considerations

Respiratory depression is the most concerning side effect across all sedation agents 9. Careful preparation and titration prevent harmful sequelae.

Allergy concerns:

• Latex allergy affects 1.4% of population; high-risk groups include spina bifida patients and those with multiple surgeries 8
• Neuromuscular blockers have high cross-sensitivity - avoid all if previous reaction 8
• Amide local anesthetics have extremely rare allergy 8

Pediatric-specific issues:

• Neonates/former preterm infants: prolonged sedation due to immature hepatic/renal function 3
• Increased postanesthesia apnea risk in former preterm infants 3

Titration principles:

• Administer IV drugs in small increments 12
• Allow sufficient time between doses for peak effect 12
• Non-IV routes require longer intervals before supplementation 12